NET PROFIT (x1000 SEK)
EMPLOYEES
Fisher Scientific Biotech Line A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
15,234
|
187,277
|
-9,434 |
| Total assets |
18,445,953
|
11,838,432
|
11,030,344 |
| Current assets |
57,112
|
52,290
|
198,851 |
| Current liabilities |
114,408
|
104,233
|
709,177 |
| Equity capital |
18,331,545
|
11,734,199
|
10,321,166 |
| - share capital |
747
|
751
|
690 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
99.4%
|
99.1%
|
93.6% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
49.9%
|
50.2%
|
28.0% |
| Return on equity (ROE) |
0.1%
|
1.6%
|
-0.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.